Menu Search
Equities

Hydreight Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SO6:FRA

Hydreight Technologies Inc

Actions
  • Price (EUR)2.32
  • Today's Change-0.06 / -2.52%
  • Shares traded500.00
  • 1 Year change+91.74%
  • Beta0.4820
Data delayed at least 15 minutes, as of Feb 10 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hydreight Technologies Inc. is a Canada-based company, which is engaged in providing health & wellness services. Its proprietary, fully integrated platform hosts a network of over 3000 nurses, over 200 doctors, and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. The Company has a 503B pharmacy network and is affiliated with a U.S. certified e-script and telemedicine provider network.

  • Revenue in CAD (TTM)24.48m
  • Net income in CAD453.24k
  • Incorporated2018
  • Employees--
  • Location
    Hydreight Technologies Inc800-1500 West Georgia StreetVancouver V6G 2ZCanadaCAN
  • Websitehttps://hydreight.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.